Placental Stem Cell Therapy Market to reach US$ 4.4 billion in 2030, expanding at a CAGR of 20%: TMR Report

WILMINGTON, DE / ACCESSWIRE / June 9, 2023 / Transparency Market Research Inc. - The global placental stem cell therapy market is projected to flourish at a CAGR of 20% from 2020 to 2030. As per the report published by TMR, the global placental stem cell therapy market is expected to exceed a value of US$4.4 billion by 2030. The market was valued at over US$0.5billion in 2020.

The increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and neurodegenerative conditions, is a significant driver for the placental stem cell therapy market. Increasing approval of GMP certification facilities to generate placental stem cells and expanding placental stem cell research activities are expected to drive the placental stem cell therapy market growth.

Unlock Insights: Download a Sample PDF Copy of this Research Report

The increased number of placement cell storage banks and increased awareness among the people is the main factor driving the growth of the placental stem cell therapy market. Favorable regulatory frameworks and guidelines for the development and use of stem cell therapies, including placental stem cell therapies, have created a favorable environment for market growth.

Increasing investments and funding in the field of regenerative medicine and stem cell therapies contribute to the growth of the placental stem cell therapy market.

Key Takeaways from the Market Report

• As of 2023, the placental stem cell therapy market is forecast to reach US$ 1.1 billion
• By Application, the neurological disorder segment is expected to account for key market share in 2023
• Based on end-user, the hospital & specialty clinic segment remains the most favored medical setting in the placental stem cell therapy market
• North America is projected to be the lucrative market for placental stem cell therapy market

The Placental Stem Cell Therapy Market: Prominent Drivers and Trends

• The growing technological advancements in the manufacturing techniques for placental stem cell therapies such as developing scalable and standardized manufacturing processes to ensure consistent quality and potency of stem cell products to drive market growth during the forecast period.
• Increasing demand for cell therapy in neurological disorders and the use of combined transplantation of allogeneic stem cells offer an opportunity for market expansion.
• Technological innovation and an increase in research & development activities and market players are actively working towards obtaining regulatory approvals, establishing distribution networks, and launching their products in the market.

Your Research, Your Way: Customized Solutions at Your Fingertips

The Placental Stem Cell Therapy Market: Regional Analysis

• North America is a significant market for placental stem cell therapy, driven by factors such as advanced healthcare infrastructure, robust research and development activities, and supportive regulatory frameworks. The United States, in particular, is a key contributor to the market, with a strong presence of research institutions, biotechnology companies, and healthcare providers actively engaged in the development and commercialization of placental stem cell therapies.
• The Asia Pacific region is experiencing rapid growth in the placental stem cell therapy market. Countries like China, Japan, South Korea, and India have significant investments in regenerative medicine and stem cell research. Factors such as a large patient population, increasing healthcare expenditure, and government initiatives to promote advanced therapies contribute to the market's expansion in this region.

Competitive Landscape

Transparency Market Research has profiled the following players in its global placental stem cell therapy market report:

• Lifebank Stem Cell Banking
• Celularity, Inc.
• Americord Registry
• ReeLabs Pvt. Ltd.
• Pluristem Therapeutics, Inc.
• Mesoblast Limited
• ReNeuron Group plc
• Athersys, Inc.

The key placental stem cell therapy market players are engaged in regulatory approvals, the launch of new products, and new and strategic collaborations. Some specific developments are as follows:

• Celularity is a biotechnology company that specializes in developing novel cellular therapies using placental-derived cells. They have a proprietary platform called CYNK-001, which consists of natural killer (NK) cells derived from placental sources. Celularity has been conducting clinical trials to evaluate the safety and efficacy of their NK cell-based therapies in various cancer indication
• Pluristem is a leading regenerative medicine company that focuses on developing placental-based cell therapies. They have been involved in clinical trials exploring the therapeutic potential of their placental-derived cell products for various indications, including critical limb ischemia, muscle injury, and hematological conditions.

Accelerate Your Growth. Get Your Copy of this Premium Research Report Now!

Placental Stem Cell Therapy Market - Segmentation

Application

• Hematologic Malignancies and Disorders
• Congenital Immunodeficiency Disorders
• Metabolic Disorders
• Neurological Disorders

End User

• Hospitals & Specialty Clinics
• Clinical Research Organizations
• Research Institutes & Academies

Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

SOURCE: Transparency Market Research inc.

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.